2 results
Approved WMOPending
This study is being performed to evaluate the cognitive and psychomotor effects of the new compound LY2624803 after bedtime dosing.
Approved WMOCompleted
To obtain user and medical staff feed-back on the safety, clinical performance and ergonomic features of the IPS and IBO.